Annual CFO
-$38.86 M
-$20.77 M-114.82%
31 December 2023
Summary:
Dare Bioscience annual cash flow from operations is currently -$38.86 million, with the most recent change of -$20.77 million (-114.82%) on 31 December 2023. During the last 3 years, it has fallen by -$13.62 million (-53.98%). DARE annual CFO is now -10336.93% below its all-time high of -$372.30 thousand, reached on 31 December 2016.DARE Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$5.92 M
-$18.83 M-145.91%
30 September 2024
Summary:
Dare Bioscience quarterly cash flow from operations is currently -$5.92 million, with the most recent change of -$18.83 million (-145.91%) on 30 September 2024. Over the past year, it has increased by +$2.05 million (+25.71%). DARE quarterly CFO is now -124.38% below its all-time high of $24.30 million, reached on 30 September 2016.DARE Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$8.01 M
+$2.05 M+20.37%
30 September 2024
Summary:
Dare Bioscience TTM cash flow from operations is currently -$8.01 million, with the most recent change of +$2.05 million (+20.37%) on 30 September 2024. Over the past year, it has increased by +$28.56 million (+78.10%). DARE TTM CFO is now -133.42% below its all-time high of $23.97 million, reached on 30 June 2017.DARE TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DARE Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -114.8% | +25.7% | +78.1% |
| 3 y3 years | -54.0% | -548.7% | +71.4% |
| 5 y5 years | -278.4% | -86.3% | +34.4% |
DARE Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -114.8% | at low | -145.9% | +63.2% | at high | +79.4% |
| 5 y | 5 years | -278.4% | at low | -145.9% | +63.2% | at high | +79.4% |
| alltime | all time | <-9999.0% | at low | -124.4% | +63.2% | -133.4% | +80.3% |
Dare Bioscience Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$5.92 M(-145.9%) | -$8.01 M(-20.4%) |
| June 2024 | - | $12.90 M(-289.4%) | -$10.06 M(-66.0%) |
| Mar 2024 | - | -$6.81 M(-16.7%) | -$29.55 M(-23.9%) |
| Dec 2023 | -$38.86 M(+114.8%) | -$8.18 M(+2.6%) | -$38.86 M(+6.2%) |
| Sept 2023 | - | -$7.97 M(+21.1%) | -$36.57 M(+82.9%) |
| June 2023 | - | -$6.59 M(-59.1%) | -$20.00 M(-8.5%) |
| Mar 2023 | - | -$16.12 M(+173.3%) | -$21.86 M(+20.9%) |
| Dec 2022 | -$18.09 M(-37.1%) | -$5.90 M(-168.6%) | -$18.09 M(-18.2%) |
| Sept 2022 | - | $8.60 M(-201.8%) | -$22.11 M(-24.8%) |
| June 2022 | - | -$8.45 M(-31.6%) | -$29.39 M(-10.2%) |
| Mar 2022 | - | -$12.34 M(+24.5%) | -$32.73 M(+13.8%) |
| Dec 2021 | -$28.76 M(+14.0%) | -$9.92 M(-851.0%) | -$28.76 M(+2.6%) |
| Sept 2021 | - | $1.32 M(-111.2%) | -$28.04 M(-19.2%) |
| June 2021 | - | -$11.79 M(+40.8%) | -$34.72 M(+28.5%) |
| Mar 2021 | - | -$8.38 M(-8.9%) | -$27.01 M(+7.1%) |
| Dec 2020 | -$25.23 M(+89.5%) | -$9.19 M(+71.6%) | -$25.23 M(+27.1%) |
| Sept 2020 | - | -$5.36 M(+31.1%) | -$19.85 M(+12.3%) |
| June 2020 | - | -$4.09 M(-38.1%) | -$17.67 M(+6.4%) |
| Mar 2020 | - | -$6.60 M(+73.2%) | -$16.60 M(+24.7%) |
| Dec 2019 | -$13.32 M(+29.7%) | -$3.81 M(+19.8%) | -$13.32 M(+9.0%) |
| Sept 2019 | - | -$3.18 M(+5.4%) | -$12.22 M(+3.6%) |
| June 2019 | - | -$3.02 M(-8.8%) | -$11.79 M(+2.9%) |
| Mar 2019 | - | -$3.31 M(+22.1%) | -$11.46 M(+11.6%) |
| Dec 2018 | -$10.27 M | -$2.71 M(-1.5%) | -$10.27 M(+20.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2018 | - | -$2.75 M(+2.3%) | -$8.52 M(+18.5%) |
| June 2018 | - | -$2.69 M(+26.9%) | -$7.19 M(+56.0%) |
| Mar 2018 | - | -$2.12 M(+120.5%) | -$4.61 M(+81.4%) |
| Dec 2017 | -$2.54 M(+582.3%) | -$961.10 K(-32.3%) | -$2.54 M(+45.5%) |
| Sept 2017 | - | -$1.42 M(+1194.6%) | -$1.75 M(-107.3%) |
| June 2017 | - | -$109.60 K(+116.6%) | $23.97 M(+86.7%) |
| Mar 2017 | - | -$50.60 K(-69.7%) | $12.84 M(-3548.1%) |
| Dec 2016 | -$372.30 K(-98.8%) | -$167.00 K(-100.7%) | -$372.30 K(-95.6%) |
| Sept 2016 | - | $24.30 M(-316.1%) | -$8.42 M(-79.3%) |
| June 2016 | - | -$11.24 M(-15.2%) | -$40.68 M(+9.2%) |
| Mar 2016 | - | -$13.26 M(+61.5%) | -$37.23 M(+16.7%) |
| Dec 2015 | -$31.91 M(+67.4%) | -$8.21 M(+3.1%) | -$31.91 M(+8.9%) |
| Sept 2015 | - | -$7.97 M(+2.2%) | -$29.31 M(+9.0%) |
| June 2015 | - | -$7.80 M(-1.8%) | -$26.90 M(+15.3%) |
| Mar 2015 | - | -$7.94 M(+41.6%) | -$23.34 M(+22.4%) |
| Dec 2014 | -$19.06 M(+14.7%) | -$5.61 M(+0.9%) | -$19.06 M(+14.0%) |
| Sept 2014 | - | -$5.56 M(+31.4%) | -$16.72 M(+16.3%) |
| June 2014 | - | -$4.23 M(+15.4%) | -$14.39 M(-8.2%) |
| Mar 2014 | - | -$3.67 M(+12.1%) | -$15.68 M(-5.6%) |
| Dec 2013 | -$16.61 M(-20.9%) | -$3.27 M(+1.6%) | -$16.61 M(+24.5%) |
| Sept 2013 | - | -$3.22 M(-41.7%) | -$13.34 M(+31.8%) |
| June 2013 | - | -$5.52 M(+20.0%) | -$10.12 M(+120.0%) |
| Mar 2013 | - | -$4.60 M | -$4.60 M |
| Dec 2012 | -$21.00 M | - | - |
FAQ
- What is Dare Bioscience annual cash flow from operations?
- What is the all time high annual CFO for Dare Bioscience?
- What is Dare Bioscience annual CFO year-on-year change?
- What is Dare Bioscience quarterly cash flow from operations?
- What is the all time high quarterly CFO for Dare Bioscience?
- What is Dare Bioscience quarterly CFO year-on-year change?
- What is Dare Bioscience TTM cash flow from operations?
- What is the all time high TTM CFO for Dare Bioscience?
- What is Dare Bioscience TTM CFO year-on-year change?
What is Dare Bioscience annual cash flow from operations?
The current annual CFO of DARE is -$38.86 M
What is the all time high annual CFO for Dare Bioscience?
Dare Bioscience all-time high annual cash flow from operations is -$372.30 K
What is Dare Bioscience annual CFO year-on-year change?
Over the past year, DARE annual cash flow from operations has changed by -$20.77 M (-114.82%)
What is Dare Bioscience quarterly cash flow from operations?
The current quarterly CFO of DARE is -$5.92 M
What is the all time high quarterly CFO for Dare Bioscience?
Dare Bioscience all-time high quarterly cash flow from operations is $24.30 M
What is Dare Bioscience quarterly CFO year-on-year change?
Over the past year, DARE quarterly cash flow from operations has changed by +$2.05 M (+25.71%)
What is Dare Bioscience TTM cash flow from operations?
The current TTM CFO of DARE is -$8.01 M
What is the all time high TTM CFO for Dare Bioscience?
Dare Bioscience all-time high TTM cash flow from operations is $23.97 M
What is Dare Bioscience TTM CFO year-on-year change?
Over the past year, DARE TTM cash flow from operations has changed by +$28.56 M (+78.10%)